Culture

New bacterial culture methods could result in the discovery of new species

image: The semi-arid Tabernas Desert in the province of Almería, Spain

Image: 
Molina-Menor, Gimeno-Valero, Peretó and Porcar

Microorganisms are the most abundant and diverse form of life on Earth. However, the vast majority of them remain unknown. Indeed, only a small fraction of the microorganisms of our planet can be cultured under traditional conditions, leaving a world of unculturable organisms out of our scope. This is especially true for bacteria thriving under extreme conditions as the harsh conditions are hardly reproducible in a lab. While some microbial studies have been performed in the Sahara, the Atacama, and the Gibson desert, European arid lands remain poorly studied.

To finally explore the microbial community of some European deserts, researchers from the University of Valencia and the Darwin Bioprospecting Excellence, here studied the bacterial diversity of the semi-arid Tabernas Desert. To this aim, the team developed new bacterial culture approaches.

"Culturomics of the Tabernas desert was the ideal crossroad between a rare, poorly studied environment, and the application of simple, yet powerful culturing techniques including long incubation times, diluted media, and careful colony picking", says Dr Manuel Porcar, group leader at the University of Valencia, president of Darwin Bioprospecting Excellence, and last author of the study.

The researchers experimented with different culture methods to find permissive conditions for some unculturable species. Their strategy lied in combining different media, using serial dilutions of the nutrients (up to a hundred times), and extending incubation time (up to a month). In total, 254 bacterial strains were isolated. Most of the species isolated from the concentrated media were previously described as soil inhabitants or species isolated from other deserts. However, 60% of the strains isolated from the highly diluted media are non-identified and possibly new bacteria species. Besides, playing on incubation times also allowed, after a month, to isolate some oligotrophic strains (slow-growing bacteria living under low nutrient conditions) otherwise difficult to growth under lab conditions.

Altogether, this study highlights the potential of simple strategies to obtain higher microbial diversity from natural samples, especially if taken from extreme environments. But the unexploited bacterial biodiversity of the Tabernas Desert could have impacts well beyond ecology and bacteriology:

"We are currently characterising several of the unidentified bacteria, three of them being new Kineococcus species. I am certain that some bacterial strains produce biotechnologically relevant products. It is just a matter to carry out the right screening", says Porcar.

Credit: 
Frontiers

Leaf fossils show severe end-Cretaceous plant extinction in southern Argentina

image: The scientists examined more than 3,500 fossils to identify survivor pairs - plants that grew in both the Cretaceous and Paleogene periods. The two fossils on the left are from the Cretaceous, and the two on the right are from the Paleogene.

Image: 
Elena Stiles

The asteroid impact 66 million years ago that ushered in a mass extinction and ended the dinosaurs also killed off many of the plants that they relied on for food. Fossil leaf assemblages from Patagonia, Argentina, suggest that vegetation in South America suffered great losses but rebounded quickly, according to an international team of researchers.

"Every mass extinction event is like a reset button, and what happens after that reset depends on which organisms survive and how they shape the biosphere," said Elena Stiles, a doctoral student at the University of Washington who completed the research as part of her master's thesis at Penn State. "All the biodiversity that we observe today is related to the organisms that made it past the last big reset 66 million years ago."

Stiles and her colleagues examined more than 3,500 leaf fossils collected at two sites in Patagonia to identify how many species from the geologic period known as the Cretaceous survived the mass extinction event into the Paleogene period. Although plant families in the region fared well, the scientists found a surprising species-level extinction rate that may have reached as high as 92% in Patagonia, higher than previous studies have estimated for the region.

"There's this idea that the Southern Hemisphere got off easier from the Cretaceous-Paleogene extinction than the Northern Hemisphere because we keep finding plant and animal groups that no one thought survived," said Peter Wilf, professor of geosciences at Penn State and associate in the Earth and Environmental Systems Institute. "We went into this study expecting that Patagonia was a refuge, and instead we found a complex story of extinction and rebound."

Researchers from Penn State; the Museo Paleontologico Egidio Feruglio (MEF), Chubut, Argentina; Universidad Nacional del Comahue INIBIOMA, Rio Negro, Argentina; and Cornell University had been collecting the fossils for years from the two sites, in what is now Chubut province. Unlike North America, where the Cretaceous-Paleogene (K-Pg) boundary is well known from many sites in the western United States, the fossil record from this period is fragmented across the Southern Hemisphere, a result of rapidly changing ancient environments.

"Most of the Cretaceous-Paleogene boundary interval known from the Southern Hemisphere is marine," said Ari Iglesias, a researcher at Universidad Nacional del Comahue INIBIOMA. "We were interested in obtaining the continental record, what happened on land. So, in this study we tried to get as close to the K-Pg boundary as possible, and we reached it in a small area in Chubut province. There we found floras right before the K-Pg boundary, or Maastrichtian floras, and right after the K-Pg boundary, so Danian age floras."

The assemblages that the team obtained constitute the most complete collection of late Cretaceous and early Paleogene fossil floras in the Southern Hemisphere, added Iglesias.

The researchers studied the assemblages for survivor pairs -- plants that grew in both the Cretaceous and Paleogene periods -- and found few species-level matches. They then compared their findings to previous pollen and insect herbivory studies from the same area and to North American fossil records. Their study, which is the first of its kind in the Southern Hemisphere, appears in the journal Paleobiology.

"The 92% extinction estimate we get when we consider fossil leaf species across the K-Pg boundary should be taken as a maximum" Stiles said. "We were surprised to find such high extinction levels compared with the 60% extinction rate seen in North America. Nonetheless, we observed a sharp drop in plant species diversity and a high species-level extinction."

Ecosystem recovery likely took millions of years, added Stiles, which is a small fraction of Earth's nearly 4.5-billion-year history.

Stiles also led a novel morphospace analysis to identify changes in leaf shape from the Cretaceous to the Paleogene, as such changes could provide clues to the kinds of environmental and climatic occurrences that took place across the boundary interval. She studied each leaf fossil for nearly 50 features, including shape, size and venation patterns.

The analysis showed a higher diversity of leaf forms in the Paleogene, which surprised the researchers given the high species-level extinction and drop in number of species at the end of the Cretaceous. They also found an increase in the proportion of leaf shapes typically found in cooler environments, which suggests that climatic cooling occurred after the end-Cretaceous extinction event.

The researchers' findings, combined with those of previous studies, suggest that despite the high species-level extinction at the end of the Cretaceous, South American plant families largely survived and grew more diverse during the Paleogene. Among the survivors were the laurel family, which today includes plants such as bay leaves and avocados, and the rose family, which includes fruit like raspberries and strawberries.

"Plants are often overlooked in these big events in geologic history," Stiles said. "But really, because plants are the primary producers on terrestrial landscapes and sustain all other life forms on Earth, we should be paying closer attention to the plant fossil record. It can tell us how the landscape changed and how those changes affected different groups of organisms."

Credit: 
Penn State

Pollen levels might trigger flares of urologic chronic pelvic pain

January 5, 2021 - As anyone living with hay fever can attest, days with high pollen counts can bring attacks of sneezing, nasal congestion and other allergy symptoms. Now, a new study suggests rising pollen levels may also trigger flare-ups of pain and other symptoms in patients with urologic chronic pelvic pain syndrome (UCPPS), reports The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

"Our study provides evidence to suggest increased pollen counts may trigger symptom flares in people living with UCPPS," comments Siobhan Sutcliffe, PhD, ScM, MHS, of Washington University School of Medicine, St Louis. "If the association with pollen levels is confirmed through future studies, it may help us to understand how flares occur in individuals with urologic chronic pelvic pain, as well as how to prevent or treat these otherwise unpredictable attacks."

Patients with UCPPS experience flares of pelvic or bladder pain and urinary symptoms, which can be frequent and disabling. The cause of UCPPS is unknown, but talking to patients provides some intriguing clues - including the fact that patients with UCPPS report higher than average rates of allergies and asthma.

What's more, some patients find their symptoms are improved when they take allergy medications. Some drugs used for allergy treatment, such as antihistamines and mast cell inhibitors, are also used for treating patients with UCPPS and other chronic pelvic pain diagnoses. If there is a link between UCPPS and allergies, then symptom flares might be more common when pollen counts are higher.

Dr. Sutcliffe and colleagues explored this association using data on patients with UCPPS enrolled in an ongoing study (Multidisciplinary Approach to the Study of Chronic Pelvic Pain, or MAPP). In 290 participants, pollen levels were compared for times when the patients were versus were not having symptom flares. They were part of an overall group of 409 patients followed up with over time to assess the overall relationship between flare rates and pollen levels. Patients were drawn from eight study sites across the United States. Information on UCPPS flares was compared with pollen levels, based on local air quality monitoring data from each study area.

Day-to-day changes in pollen counts were not related to UCPPS flares, either on the day of a flare or the preceding three days. This was the case for all participants and on analysis of those reporting allergies or respiratory tract disorders.

However, when pollen counts rose beyond the medium or high threshold, UCPPS flares significantly increased. One to two days after pollen counts exceeded the "medium" or higher threshold, the odds of a symptom flare increased by 22 percent in all patients with UCPPS, and by 33 percent in those with allergies.

Flare rates also increased in the three weeks after pollen counts exceeded medium or high thresholds, with a significant 23 percent increase in risk for patients with allergies. The results remained about the same on analysis excluding patients who were taking UCPPS medications with anti-allergy effects.

"Our results are consistent with patients reporting that higher pollen counts trigger their flares and with case series and report data suggesting allergy and asthma medications relieve UCPPS symptoms," Dr. Sutcliffe and coauthors write. The findings are also supported by evidence that UCPPS and allergies share common biological factors, i.e., mast cell activation and histamine release. After histamine is released in response to allergens, levels remain elevated in the urine for some time - which might contribute to bladder-related symptoms in UCPPS.

While the findings provide new evidence of a link between allergies and UCPPS, the researchers note some limitations of their study - not all of the observed associations were statistically significant. "If pollen does indeed trigger flares for some patients with urologic chronic pelvic pain, that might have implications for further research and patient care," Dr. Sutcliffe adds. "For example, patients may benefit from taking antihistamines on days with high pollen levels, or from allergy testing and immunotherapy."

Credit: 
Wolters Kluwer Health

Remote sensing data sheds light on when and how asteroid Ryugu lost its water

image: Japan's Hayabusa2 spacecraft snapped pictures of the asteroid Ryugu while flying alongside it two years ago. The spacecraft later returned rock samples from the asteroid to Earth.

Image: 
JAXA

PROVIDENCE, R.I. [Brown University] -- Last month, Japan's Hayabusa2 mission brought home a cache of rocks collected from a near-Earth asteroid called Ryugu. While analysis of those returned samples is just getting underway, researchers are using data from the spacecraft's other instruments to reveal new details about the asteroid's past.

In a study published in Nature Astronomy, researchers offer an explanation for why Ryugu isn't quite as rich in water-bearing minerals as some other asteroids. The study suggests that the ancient parent body from which Ryugu was formed had likely dried out in some kind of heating event before Ryugu came into being, which left Ryugu itself drier than expected.

"One of the things we're trying to understand is the distribution of water in the early solar system, and how that water may have been delivered to Earth," said Ralph Milliken, a planetary scientist at Brown University and study co-author. "Water-bearing asteroids are thought to have played a role in that, so by studying Ryugu up close and returning samples from it, we can better understand the abundance and history of water-bearing minerals on these kinds of asteroids."

One of the reasons Ryugu was chosen as a destination, Milliken says, is that it belongs to a class of asteroids that are dark in color and suspected to have water-bearing minerals and organic compounds. These types of asteroids are believed to be possible parent bodies for dark, water- and carbon-bearing meteorites found on Earth known as carbonaceous chondrites. Those meteorites have been studied in great detail in laboratories around the world for many decades, but it is not possible to determine with certainty which asteroid a given carbonaceous chondrite meteorite may come from.

The Hayabusa2 mission represents the first time a sample from one of these intriguing asteroids has been directly collected and returned to Earth. But observations of Ryugu made by Hayabusa2 as it flew alongside the asteroid suggest it may not to be as water-rich as scientists originally expected. There are several competing ideas for how and when Ryugu may have lost some of its water.

Ryugu is a rubble pile -- a loose conglomeration of rock held together by gravity. Scientists think these asteroids likely form from debris left over when larger and more solid asteroids are broken apart by a large impact event. So it's possible the water signature seen on Ryugu today is all that remains of a previously more water-rich parent asteroid that dried out due a heating event of some kind. But it could also be that Ryugu dried out after a catastrophic disruption and re-formation as a rubble pile. It's also possible that Ryugu had a few close spins past the sun in its past, which could have heated it up and dried out its surface.

The Hayabusa2 spacecraft had equipment aboard that could help scientists to determine which scenario was more likely. During its rendezvous with Ryugu in 2019, Hayabusa2 fired a small projectile into the asteroid's surface. The impact created a small crater and exposed rock buried in the subsurface. Using a near-infrared spectrometer, which is capable of detecting water-bearing minerals, the researchers could then compare the water content of surface rock with that of the subsurface.

The data showed the subsurface water signature to be quite similar to that of the outermost surface. That finding is consistent with the idea that Ryugu's parent body had dried out, rather than the scenario in which Ryugu's surface was dried out by the sun.

"You'd expect high-temperature heating from the sun to happen mostly at the surface and not penetrate too far into the subsurface," Milliken said. "But what we see is that the surface and subsurface are pretty similar and both are relatively poor in water, which brings us back to the idea that it was Ryugu's parent body that had been altered."

More work needs to be done, however, to confirm the finding, the researchers say. For example, the size of the particles excavated from the subsurface could influence the interpretation of the spectrometer measurements.

"The excavated material may have had a smaller grain size than what's on the surface," said Takahiro Hiroi, a senior research associate at Brown and study co-author. "That grain size effect could make it appear darker and redder than its coarser counterpart on the surface. It's hard to rule out that grain-size effect with remote sensing."

Luckily, the mission isn't limited to studying samples remotely. Since Hayabusa2 successfully returned samples to Earth in December, scientists are about to get a much closer look at Ryugu. Some of those samples may soon be coming to the NASA Reflectance Experiment Laboratory (RELAB) at Brown, which is operated by Hiroi and Milliken.

Milliken and Hiroi say they're looking forward to seeing if the laboratory analyses corroborate the team's remote sensing results.

"It's the double-edged sword of sample return," Milliken said. "All of those hypotheses we make using remote sensing data will be tested in the lab. It's super-exciting, but perhaps also a little nerve-wracking. One thing is for certain, we're sure to learn a lot more about the links between meteorites and their parent asteroids."

Credit: 
Brown University

Self-controlled children tend to be healthier middle-aged adults

DURHAM, N.C. -- Self-control, the ability to contain one's own thoughts, feelings and behaviors, and to work toward goals with a plan, is one of the personality traits that makes a child ready for school. And, it turns out, ready for life as well.

In a large study that has tracked a thousand people from birth through age 45 in New Zealand, researchers have determined that people who had higher levels of self-control as children were aging more slowly than their peers at age 45. Their bodies and brains were healthier and biologically younger.

In interviews, the higher self-control group also showed they may be better equipped to handle the health, financial and social challenges of later life as well. The researchers used structured interviews and credit checks to assess financial preparedness. High childhood self-control participants expressed more positive views of aging and felt more satisfied with life in middle age.

"Our population is growing older, and living longer with age-related diseases," said Leah Richmond-Rakerd, an assistant professor of psychology at the University of Michigan, who is the first author on the study. "It's important to identify ways to help individuals prepare successfully for later-life challenges, and live more years free of disability. We found that self-control in early life may help set people up for healthy aging."

The children with better self-control tended to come from more financially secure families and have higher IQ. However, the findings of slower aging at age 45 with more self-control can be separated from their childhood socio-economic status and IQ. Their analyses showed that self-control was the factor that made a difference.

And childhood is not destiny, the researchers are quick to point out. Some study participants had shifted their self-control levels as adults and had better health outcomes than their childhood assessments would have predicted.

Self-control also can be taught, and the researchers suggest that a societal investment in such training could improve life span and quality of life, not only in childhood, but also perhaps in midlife. There is ample evidence that changing behaviors in midlife (quitting smoking or taking up exercise) leads to improved outcomes.

"Everyone fears an old age that's sickly, poor, and lonely, so aging well requires us to get prepared, physically, financially, and socially," said Terrie Moffitt, the Nannerl O. Keohane Professor of Psychology & Neuroscience at Duke, and last author on the paper. "We found people who have used self-control since childhood are far more prepared for aging than their same-age peers."

The study appears the week of Jan. 4 in the Proceedings of the National Academy of Sciences.

The Dunedin Multidisciplinary Health and Development Study, based in New Zealand, has tracked these people since they were born in 1972 and 73, putting them through a battery of psychological and health assessments at regular intervals since, the most recent being at age 45.

Childhood self-control was assessed by teachers, parents and the children themselves at ages 3, 5, 7, 9 and 11. The children were measured for impulsive aggression and other forms of impulsivity, over-activity, perseverance and inattention.

From ages 26 to 45, the participants also were measured for physiological signs of aging in several organ systems, including the brain. In all measures, higher childhood self-control correlated with slower aging.

The people with the highest self-control were found to walk faster and have younger-looking faces at age 45 as well.

"But if you aren't prepared for aging yet, your 50's is not too late to get ready," Moffitt added.

Credit: 
Duke University

Evolving the surgical microscope

image: Surgical microscope with integrated near-infrared photoacoustic OCT, from D. Lee et al., doi 10.1038/srep35176

Image: 
D. Lee et al., doi 10.1038/srep35176

A clear view of anatomical structures is vital for the success of surgery--especially in microsurgery where narrow anatomical cavities or proximity to vulnerable organs and tissues can pose significant risks to patient health. The surgical microscope has evolved to become a powerful tool for improving surgical visualization.

A comprehensive review of surgical microscopes, authored by Baowei Fei, professor of bioengineering and radiology at University of Texas at Dallas, and bioengineering doctoral candidate Ling Ma, relates the evolution of surgical microscopes as they have developed with wider ranges of magnification, longer working distances, better illumination, and more stable supporting structures. Ma and Fei explain how surgical microscopes are modified into slightly different optical configurations and equipped with specific imaging modalities and platforms for different surgical applications.

Beyond the loupe

The first reported surgical microscope in an operating room was used by a young otolaryngology surgeon named Carl Olof Nylén in 1921 at the University of Stockholm. Nylén used a monocular Brinell-Leitz microscope during surgery on a patient with a chronic ear infection. This was a step up from a single lens loupe. The tool was updated a year later by Gunnar Holmgren who developed a binocular microscope for depth perception and an attached light source to accompany the magnification. Holmgren would scarcely recognize today's surgical microscopes with adjustable magnification, bright and shadow-free illumination, variable working distance to allow manipulation of surgical instruments, and a stable, unobstructed view of the entire operating field.

Though surgical microscopes were not introduced into neurosurgical operating rooms until 1957, when Theodor Kurze at University of Southern California removed a benign tumor from a cranial nerve in a 5-year-old patient, neurosurgery is now the leading market for surgical microscopes.

Versatile visualization, integrated imaging modalities

Surgical microscopy has come a long way. In addition to high-precision optics and flexible mechanical design, versatile visualization features such as 3D display are now included, as well as integrated imaging modalities. Augmented reality displays, which overlay real-life structures with, say, MRI or OCT images of the structures, improve visualization of the surgical field as well as the multimodal images. Such advanced capabilities are changing clinical practice in the operating room, enabling surgeons to see better and perform challenging procedures with greater ease and success.

Hyperspectral imaging (HSI) and laser speckle contrast imaging (LSCI) modalities are particularly promising since they can be used on-demand anytime during surgery and provide abundant real-time diagnostic data as noncontact and label-free imaging modalities. Ma and Fei note that both HSI and LSCI add very little complexity to the system and take minimal effort for physicians to adopt.

The visualization capabilities and integrated technologies in surgical microscopes continue to expand. With advanced communication technologies and well-developed augmented-reality-assisted platforms, large groups will be able to participate remotely in surgical procedures, sharing a clear view of the surgical field via headsets, smartphones, or large conference room screens.

Robotic visualization platforms allow freedom of movement for the surgeon and enable the whole team to observe detailed structures. Integrated technologies, such as an endoscopic micro-inspection tool, can enable the surgeon to "bookmark" a position of the surgical field and visualize the same structure at different angles. Such systems enrich the concept of the surgical microscope with multiple cutting-edge technologies and also provide clear advantages in time, functionality, and ergonomics.

First utilized for otolaryngology, surgical microscopes are contributing to a wide array of microsurgeries, from lymphatic reconstruction to nerve repair. Increasing clinical use of surgical microscopes can be anticipated, and in a greater range of surgical applications.

Credit: 
SPIE--International Society for Optics and Photonics

Bone fracture risk may increase when critical enzymatic processes decline

TROY, N.Y. -- A loss of enzymatic processes within the body can increase a person's risk of bone fracture. This new insight was recently published in eLife by an international team of scientists and engineers led by Deepak Vashishth, the director of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute.

Enzymatic processes are essential to any number of chemical reactions that occur within the body, including the production of the extracellular matrix within bone that is critical for mechanical support. Phosphorylation -- one of those key enzymatic processes -- is the attachment of a phosphoryl to a protein, and is critical for cellular regulation. This process plays a role in many diseases, but until now, researchers didn't know if it altered tissue integrity and organ function.

In this paper, researchers looked at a protein known as osteopontin, which plays a vital role in holding the matrix together. The researchers developed a process by which they could induce phosphorylation -- or its counterpart, dephosphorylation -- in bones from genetically modified mice, some that had osteopontin and others that did not. By comparing results from the two groups, researchers found that fracture toughness, a measure of bone's mechanical strength, increased with osteopontin phosphorylation and declined with dephosphorylation. More specifically, phosphorylation enhanced crosslinks and increased the attraction between the charged groups on osteopontin and bone mineral, making bone stronger and its fracture more difficult.

"This is the first study that lays down that phosphorylation in bone matters, particularly how it assists bone in releasing energy, and that loss of this modification is bad for bone," Vashishth said.

The team also studied the effect of osteopontin phosphorylation levels in the rare bone diseases hypophosphatemia and hyperphosphatemia, which are associated with skeletal deformities. In both diseases, Vashishth said, osteopontin phosphorylation levels decreased, a finding that lays the groundwork for further exploration.

"Another promising discovery was that these levels do change with diseases in bone," Vashishth said. "Is phosphorylation directly affecting the fracture propensity of bones in these diseased conditions? And what therapeutic tools can we use to fix this? These are the questions that we want to investigate."

In the spirit of the New Polytechnic, the model that drives research and education at Rensselaer, this research was highly collaborative across multiple disciplines. Vashishth and his lab worked with researchers at McGill University in Canada, the University of Southampton in the United Kingdom, the University of Patras in Greece, Aarhus University in Denmark, and Vienna University of Technology in Austria. Each research team brought a different expertise and piece of this puzzle to the work.

The team's findings may also be applied to similar processes within other connective tissues and possible therapeutics to counteract abnormal osteopontin phosphorylation levels.

"This is not just specific to bone, because phosphorylation is a more ubiquitous change in other tissues in the body," Vashishth said. "Osteopontin is not only in bone, it's in other tissues in our body, like our kidneys and several other places. This research can also shed light on other things that can happen throughout the body."

Credit: 
Rensselaer Polytechnic Institute

Low genetic diversity in two manatee species off South America

image: People rescue a stranded Antillean manatee, Trichechus manatus manatus

Image: 
Luna, Beaver, Nourisson et al.

Worldwide, marine megafauna are at risk of extinction due to climate change, habitat loss, pollution, overhunting, population fragmentation, and hybridization with related species in areas disturbed by humans. Genetic studies can help determine the conservation status of marine animals, identifying threats to species conservation and informing interventions and policies, such as the protection of diversity hotspots or corridors for gene flow.

In a new study in Frontiers in Marine Science, researchers for the first time measured genetic diversity in manatees at a large geographical scale -- that is, along the northern coastline of South America. They show that the Antillean subspecies of the West Indian manatee forms a single, non-continuous population along the Brazilian coastline. Manatees from this population occasionally interbreed with the Antillean subspecies population located further North and West, between Guyana and Venezuela. Moreover, there seems to be no natural hybridization between the Antillean Amazonian manatee, even though their habitats overlap in the mouth of the Amazon river.

The Antillean subspecies of the West Indian manatee (Trichechus manatus manatus) and the Amazonian manatee (Trichechus inunguis) (order Sirenia) are both classified as Vulnerable on the IUCN Red List of Threatened Species. Antillean manatees occur across most of the Caribbean and along the Atlantic coast of Central and South America. In contrast, the Amazonian manatee is exclusively found in the mouth of the Amazon River. Historically, both were hunted intensively. Though hunting pressure has subsided, both remain at risk due to further anthropogenic threats, especially habitat degradation and collisions with boats. Manatees have strict habitat requirements, mainly places with seagrass and freshwater, such as estuaries. Due to continuous human pressure on their habitats, such as seagrass meadows, populations have decreased, potentially leading to a decrease in genetic variability.

''Genetic diversity is critical for species to be able to adapt to changing environments and avoid inbreeding and needs to be considered to allow for long-term protection of species,'' says coauthor Dr Margaret Hunter from the Wetland and Aquatic Research Center of the U.S. Geological Survey in Gainesville, Florida. "Here we show that manatee populations of Venezuela, Guyana and Brazil have some degree of interrelatedness but overall low genetic diversity.'"

To determine whether there is genetic connectivity between the West Indian and Amazonian manatee, the authors took 17 DNA samples from the Amazonian manatee, 78 from the Antillean subspecies in Brazil (southern cluster of populations) and 11 from Guyana and Venezuela (northern cluster), including adults and calves, and measured diversity at nuclear and mitochondrial neutral genetic markers.

The researchers found no evidence of natural hybridization between the two species. What they did find was evidence of gene flow between the northern and southern cluster of Antillean manatees. It seems the physical barrier of the Amazon River plume is not enough to block gene flow between the northern and southern cluster.

''These results make it possible for us to understand current genetic diversity of the Brazilian West Indian manatee population,'' says coauthor Dr Fábia de Oliveira Luna from Chico Mendes Institute for Biodiversity Conservation - National Center for Research and Aquatic Mammals Conservation, Brazil. ''We call on policymakers to improve the national action plan. An important action is the creation of new protected areas, which help establish biological corridors and promote gene flow. Another is to protect habitats where manatees give birth. Newborn calves have stranded along the Ceará and Rio Grande do Norte coastline of Brazil: upon rescue, these should released into the genetic population of origin, or in gap areas without residing manatees. In contrast, captive breeding should be avoided for now as enough calves are born in the wild."

Credit: 
Frontiers

Retracted scientific paper persists in new citations, study finds

image: Information sciences professor Jodi Schneider studied the problem of continued citation of retracted scientific papers. She led workshops for those in the academic publishing community to consider solutions to prevent the spread of retracted research.

Image: 
L. Brian Stauffer

CHAMPAIGN, Ill. -- A small portion of scientific papers are retracted for research that is in error or fraudulent. But those papers can continue to be cited by other scientists in their work, potentially passing along the misinformation from the retracted articles.

Jodi Schneider, a professor of information sciences at the University of Illinois Urbana-Champaign who studies scholarly publications and how information gets used, is considering how scientific journals can better communicate about retracted articles. In a new study published in the journal Scientometrics, she found that a retracted clinical trial report continues to be cited 11 years after its retraction - and that citations actually increased after it was retracted.

Schneider's team reviewed citations of a 2005 paper in the field of respiratory medicine that found omega-3 fatty acids to be helpful in reducing inflammatory markers in patients with chronic obstructive pulmonary disease. The paper was retracted in 2008 for reporting on falsified clinical trial data.

However, it continues to be cited to support the medical nutrition intervention. Schneider's analysis covered 148 direct citations of the paper from 2006-2019 and 2,542 second-generation citations. The retraction was not mentioned in 96% of the 112 direct post-retraction citations for which she was able to study the context of the citation. The example demonstrates problems with how the current digital library environment communicates the retraction status of scientific papers, Schneider wrote.

The number of articles that are retracted "is really, really tiny. It's a regular occurrence that things get retracted, but people publish so much," Schneider said. Since 2012, there have been about four retractions per 10,000 publications, she wrote in her article.

When a new paper is published, most journals don't check the bibliographies for citations of retracted research. "It's really rare for any journal to be scanning reference lists," Schneider said.

Notices of retractions are often hard to find. Some websites and databases, such as PubMed, make retraction notices easily visible, but many others do not, Schneider said. There may be multiple sites where a copy of a scientific paper can be found, and not all will indicate if it is retracted.

In addition, many databases don't have complete information about a retraction. Retractions can occur for a number of reasons, including errors made in the research or misconduct such as reporting fraudulent data. About 10% of retraction notices don't mention the reason for retraction, Schneider said.

"Part of the challenge is understanding the reasons why a particular article was retracted, which often are really vague," Schneider said.

How an article is cited matters - for example, whether authors seem aware of the retraction, whether they use the retracted paper as a foundation to build on with their own work or whether it is cited for a general concept or the history of research on a particular matter. Analyzing the context as well as the number of citations, Schneider found that more than 41% of the post-retraction citations of the respiratory medicine paper that did not mention the retraction also described the paper in detail.

"We looked at whether they were discussing the methods and results of the retracted paper. The more in-depth they are discussing it, the more they are using it as part of an argument for their work," she said.

Unlike with most retracted research articles, the respiratory medicine paper's citations increased substantially after the retraction, Schneider found. One likely factor influencing the number of citations the paper received is that it was the first purported random clinical trial on a research question with very little previous research, she said.
The retraction process can take a long time and involve institutional or governmental investigations, she said. The longer it takes to retract an article that is in error or fraudulent, the more likely it is to be cited in the meantime.
"The current information environment facilitates the spread of research papers, but basic facts about these papers, such as their retraction status, do not spread as swiftly as the PDFs or citations to these papers themselves. Our case study suggests that unknowing and likely unintentional citation of retracted papers could be common, and that post-retraction citation may be correlated with visibility of retraction status," Schneider wrote.

She has led several workshops for people across scholarly publishing to talk about how journals can better check for citation of retracted articles, and the workshop participants are drafting recommendations. Schneider said best practices for journals should include ensuring every retraction notice is publicly available and establishing a convention for how to flag an article that is retracted. Among the suggestions is developing a standard set of metadata regarding retractions that would be attached to articles and use a taxonomy of statuses, such as retraction or expression of concern.

Information sciences students at Illinois built a prototype tool called ReTracker that would automatically check for retractions among the articles that scholars compile in their online libraries, using data from PubMed, and add the retraction status directly into the library. Zotero, a popular reference-management software system used for managing bibliographic data and research materials, also has developed such a tool, Schneider said.

Ensuring that retracted articles don't continue to be cited as reliable research is important not just for scientists but also for public confidence in scientific research, Schneider said.

"A scientific paper that is right is like a brick to build walls of evidence we can rely on," she said.

Credit: 
University of Illinois at Urbana-Champaign, News Bureau

Hotels that promote women perceived as fairer, less discriminatory

Hotel managers have something in common beyond their reputations for charming dispositions and excellent listening skills - they're predominantly men, despite women making up the majority of the accommodations workforce. New research led by the University of Houston Conrad N. Hilton College of Hotel and Restaurant Management suggests hotel companies that promote a woman over an equally qualified man are perceived as fairer and less discriminatory, creating a stronger organizational culture and higher financial performance.

Published in the International Journal of Contemporary Hospitality Management, the study is the first to address gender inequity in promotional opportunities for hotel employees. The researchers surveyed 87 hotel managers to gauge their feelings on gender discrimination and perceived fairness of the promotion process.

Nearly 80% of managerial positions in the hospitality industry are held by men, who are given approximately 30% more promotional opportunities than women. The gender inequity in hotels is even more alarming. Women account for only 12% of all hotel leadership positions, from entry-level supervisor to owner.

"This is important because if women don't believe the promotional process is fair, they're not even going to try to apply for those positions," said Michelle Russen, PhD student and lead study author. "There needs to be more women in these top management positions. How employees perceive the fairness within the process may also directly influence the organizational culture, sales growth and employee productivity of the hotel."

Many organizations may refrain from offering more promotional opportunities to women for fear of reverse discrimination, according to the study authors. While affirmative action requiring a certain quota of female employees and other minorities may be well intentioned, men may feel as though they are discriminated against. But the results of the survey suggest that even hotel managers who believe in reverse discrimination will view promoting a female to management as a fair decision.

Fairness in the process serves as a signal to employees, said Juan Madera, UH professor and study co-author. "If a female applicant is a star, but she sees a management team that's all men, it may signal this is not a good fit for her and the company loses out on a great candidate."

Furthermore, he points out that if employees believe the promotion process is fair, then they will believe the organization will treat them fairly, too, which can affect other attitudes, including overall commitment to the company and plans to stay or move on.

The researchers hope their findings will influence hotel policies and training materials. Whether real or perceived, if there are feelings of inequity, there could be negative consequences.

"Financially there may be discrimination suits, cost of replacement of employee turnover, or reduced firm performance. Therefore, it is essential for hotels to have training and mentoring programs in which employees of both genders are encouraged to participate, to enhance perceived fairness within the organization. These programs must demonstrate the organization's commitment to advancing the careers of both genders," they wrote.

To make the process fairer, the researchers recommend creating a blind review process where initial decisions are made by removing names from employee files and objective third parties review the information and criteria for promotion, thus giving all parties a fair chance without incorporating gender, age or "like-me" biases.

"Owners and operators need to recognize that bias exists and examine how fair they're being in their processes. Beyond just promoting females from within, these findings have implications for bringing in top talent from the outside," said co-author Mary Dawson, associate dean for academic affairs and Donald H. Hubbs Professor at UH's Hilton College. "If I'm a woman doing research about a company that I applied to but only see men in management, then I'd question that company's culture."

Credit: 
University of Houston

COVID-19 unmasked: math model suggests optimal treatment strategies

BOSTON -- Getting control of COVID-19 will take more than widespread vaccination; it will also require better understanding of why the disease causes no apparent symptoms in some people but leads to rapid multi-organ failure and death in others, as well as better insight into what treatments work best and for which patients.

To meet this unprecedented challenge, researchers at Massachusetts General Hospital (MGH), in collaboration with investigators from Brigham and Women's Hospital and the University of Cyprus, have created a mathematical model based on biology that incorporates information about the known infectious machinery of SARS-CoV-2, the virus that causes COVID-19, and about the potential mechanisms of action of various treatments that have been tested in patients with COVID-19.

The model and its important clinical applications are described in the journal Proceedings of the National Academy of Sciences (PNAS).

"Our model predicts that antiviral and anti-inflammatory drugs that were first employed to treat COVID-19 might have limited efficacy, depending on the stage of the disease progression," says corresponding author Rakesh K. Jain, PhD, from the Edwin L. Steele Laboratories in the Department of Radiation Oncology at MGH and Harvard Medical School (HMS).

Jain and colleagues found that in all patients, the viral load (the level of SARS-CoV-2 particles in the bloodstream) increases during early lung infection, but then may go in different directions starting after Day 5, depending on levels of key immune guardian cells, called T cells. T cells are the first responders of the immune system that effectively coordinate other aspects of immunity. The T cell response is known as adaptive immunity because it is flexible and responds to immediate threats.

In patients younger than 35 who have healthy immune systems, a sustained recruitment of T cells occurs, accompanied by a reduction in viral load and inflammation and a decrease in nonspecific immune cells (so-called "innate" immunity). All of these processes lead to lower risk for blood clot formation and to restoring oxygen levels in lung tissues, and these patients tend to recover.

In contrast, people who have higher levels of inflammation at the time of infection -- such as those with diabetes, obesity or high blood pressure -- or whose immune systems are tilted toward more active innate immune responses but less effective adaptive immune responses tend to have poor outcomes.

The investigators also sought to answer the question of why men tend have more severe COVID-19 compared with women, and found that although the adaptive immune response is not as vigorous in women as in men, women have lower levels of a protein called TMPRSS2 that allows SARS-CoV-2 to enter and infect normal cells.

Based on their findings, Jain and colleagues propose that optimal treatment for older patients -- who are likely to already have inflammation and impaired immune responses compared with younger patients -- should include the clot-preventing drug heparin and/or the use of an immune response-modifying drug (checkpoint inhibitor) in early stages of the disease, and the anti-inflammatory drug dexamethasone at later stages.

In patients with pre-existing conditions such as obesity, diabetes and high blood pressure or immune system abnormalities, treatment might also include drugs specifically targeted against inflammation-promoting substances (cytokines, such as interleukin-6) in the body, as well as drugs that can inhibit the renin-angiotensin system (the body's main blood pressure control mechanism), thereby preventing activation of abnormal blood pressure and resistance to blood flow that can occur in response to viral infections.

This work shows how tools originally developed for cancer research can be useful for understanding COVID-19: The model was first created to analyze involvement of the renin angiotensin system in the development of fibrous tissues in tumors, but was modified to include SARS-CoV-2 infection and COVID-19-specific mechanisms. The team is further developing the model and plans to use it to examine the dynamics of the immune system in response to different types of COVID-19 vaccines as well as cancer-specific comorbidities that might require special considerations for treatment.

Credit: 
Massachusetts General Hospital

Dungeness crab fishing industry response to climate shock

image: Researchers found that 71 percent of California Dungeness crab fishing vessels temporarily left the industry and stopped fishing altogether during the delays.

Image: 
Northwest Fisheries Science Center/NOAA Fisheries

Fishermen contend with regulations, natural disasters, and the ups and downs of the stocks they fish, along with many other changes. As a result, fishing communities are quite resilient. That is, they can withstand, recover from, and adapt to change.

But how much pressure can they stand? The 2014-2016 North Pacific marine heatwave, known as the Blob, led to a harmful algal bloom of unprecedented scale. It necessitated substantial delays in the opening of the 2015-16 U.S. West Coast Dungeness crab fishery. The fishery is vital to West Coast communities. It produces around 26 percent of all annual fishing revenue and supports more than 30 percent of all commercial fishing vessels.

Understanding Impacts from Climate Shocks

Previous studies have documented the devastating economic impacts from the 2015-16 event on Dungeness crab fishermen. Members of affected coastal communities attest that these socioeconomic effects rippled through associated industries and coastal communities. But can changes in fishing practices in response to this significant climate shock be quantified?

"We wanted to examine the extent to which the Dungeness crab fishery delays affected participation in other fisheries, and the duration of those changes," said Mary Fisher, a doctoral student at the University of Washington. Fisher did the work as a National Science Foundation Graduate Research Internship Program Fellow at NOAA's Northwest Fisheries Science Center.

Fisher and her colleagues at NOAA Fisheries, University of Washington, and Oregon State University studied the impacts on more than 2,500 vessels across seven California fishing communities. The researchers wanted to see how a climate-related shock (like the heatwave and associated harmful algal bloom) can impact communities' use of ocean resources.

The researchers used 10 years of fishery landings data to map resource use networks for seven California port groups where Dungeness crab is an important revenue source. The networks visualize the portfolio of fisheries that a community harvests and how vessels move between fisheries. The network visualization is similar to a food web, except that the connections represent harvest by fishing vessels rather than predator-prey relationships.

Resilient Fishing Communities

Researchers found that 71 percent of California Dungeness crab fishing vessels temporarily left the industry and stopped fishing altogether during the delays. The two other strategies that fishermen used to cope with the disruption were:

Participating in other fisheries that were not affected by the harmful algal bloom.

Moving out of delayed areas to fish in other more favorable locations.

These strategies significantly changed communities' resource use patterns, but some communities were more affected by the climate shock than others. Researchers could predict which communities would be least sensitive to the shock by looking at their resource use patterns before the 2015-16 season.

These communities, located in central California, were less dependent on Dungeness crab and had shorter fishery delays. In these communities, fishermen had access to more open fisheries during the winter months and were more flexible in how they fished previously. These characteristics provided more options, buffering fishermen from the disruption to the Dungeness crab fishing season.

No matter how central Dungeness crab was to a community's fisheries portfolio, the researchers didn't observe any significant, lasting changes in how vessels participated in fisheries after the closures lifted. This suggests fishing communities may mostly return to "normal" fishing practices relatively quickly after short-term disturbances like climate shocks, provided those changes don't pile up one after the other.

Access to Other Fisheries and Ports Important

The results highlight the importance of nearshore groundfish fisheries like sablefish, rockfish, and lingcod as alternatives to the Dungeness crab fishery. "Most of the crab vessels that stayed out on the water were using pot or hook-and-line gear to fish groundfish," says Fisher. "I think we can expect access to these fisheries to continue to be important during crab season delays."

Fishermen with larger vessels also landed their catch at different ports, a strategy less common among smaller vessels. This was possible in part because regulations only restricted fishing in delayed areas at the district level. In 2018, the California Department of Fish and Wildlife amended these rules, called the Fair Start Provisions. The amendments provide more protection to fishermen at a finer scale than districts in the event of future delays.

Credit: 
NOAA Fisheries West Coast Region

Understanding disease-induced microbial shifts may reveal new crop management strategies

image: Orange fields and lab work

Image: 
Dr. Nichole Ginnan

While humanity is facing the COVID-19 pandemic, the citrus industry is trying to manage its own devastating disease, Huanglongbing (HLB), also known as citrus greening disease. HLB is the most destructive citrus disease in the world. In the past decade, the disease has annihilated the Florida citrus industry, reducing orange production for juice and other products by 72%. Candidatus Liberibacter asiaticus (CLas) is the microbe associated with the disease. It resides in the phloem of the tree and, like many plant pathogens, is transmitted by insects during feeding events. Disease progression can be slow but catastrophic. Symptoms begin with blotchy leaves, yellow shoots, and stunting, and progress into yield decline, poor quality fruit, and eventually death.

Currently, the only thing citrus growers can do to protect their crops from HLB is control the insect vector. Dozens of researchers are trying to find ways to manage the disease, using strategies ranging from pesticides to antibiotics to CLas-sniffing dogs. Understanding the plant microbiome, an exciting new frontier in plant disease management, is another strategy.

Dr. Caroline Roper and first author Dr. Nichole Ginnan at the University of California, Riverside led a large research collaboration that sought to explore the microbiome's role in HLB disease progression. Their recent article in Phytobiomes Journal, "Disease-Induced Microbial Shifts in Citrus Indicate Microbiome-Derived Responses to Huanglongbing," moves beyond the single-snapshot view of the microbial landscape typical of microbiome research. Their holistic approach to studying plant-microbe interactions captured several snapshots across three years and three distinct tissue types (roots, stems, and leaves). What is so interesting about this research is the use of amplicon (16S and ITS) sequencing to capture the highly intricate and dynamic role of the microbiome (both bacterial and fungal) as it changes over the course of HLB disease progression.

Ginnan et al. surmised that HLB created a diseased-induced shift of the tree's microbiome. Specifically, the researchers showed that as the disease progresses, the microbial diversity increases. They further investigated this trend to find that the increase in diversity was associated with an increase in putative pathogenic (disease-causing) and saprophytic (dead tissue-feeding) microbes. They observed a significant drop in beneficial microbes in the early phases of the disease. Arbuscular mycorrhizal fungi (AMF) were one such beneficial group that the authors highlighted as showing a drastic decline in relative abundance.

The depletion of key microbial species during disease might be opening the door for other microbes to invade. Certain resources may become more or less available, allowing different microbes to prosper. Dr. Roper and Dr. Ginnan hypothesize that when HLB begins, this depletion event triggers a surge of beneficial microbes to come to the aid of the citrus tree. They suspect that the microbes are initiating an immune response to protect the host.

As the disease proliferates, the citrus tree and its microbiome continue to change. Dr. Ginnan, the lead author on this study, found that there was an enrichment of parasitic and saprophytic microorganisms in severely diseased roots. The enrichment of these microbes may contribute to disease progression and root decline, one side effect of HLB.

Survivor trees, or trees that did not progress into severe disease, had a unique microbial profile as well. These trees were enriched with putative symbiotic microbes like Lactobacillus sp. and Aureobasidium sp. This discovery led the researchers to identify certain microbes that were associated with slower disease progression.

Dr. Ginnan says their "aha" moment during the research was in the data analysis. "Originally we were looking for taxa that increased and decreased in relative abundance as disease rating increased," she said. "Our differential abundance analysis ended up revealing clear enrichment patterns replicated in multiple taxa." This is the moment they began to develop the individual patterns they were seeing into a broader disease model.

This research is the foundation for future projects and collaborations that the authors are excited to continue to develop. They are motivated by the potential function of the microbiome to manage crop diseases. In the near future, they hope that these discoveries and an understanding of beneficial microbes can help establish a microbiome-mediated treatment plan to protect crops from diseases like HLB. In addition, the model they've developed can be applied to understanding diseases of other tree crop systems.

Credit: 
American Phytopathological Society

UC-MSC infusion helps repair COVID-19 damage in severe cases

image: Umbilical cord-derived mesenchymal stem cells naturally migrate directly to the lung where they begin repair to COVID-19 damage.

Image: 
© Dr. Camillo Ricordi

Dr. Camilo Ricordi, director of the Diabetes Research Institute (DRI) and Cell Transplant Center at the University of Miami Miller School of Medicine, and his team of international collaborators are reporting the results of a groundbreaking randomized controlled trial showing umbilical cord-derived mesenchymal stem cell (UC-MSC) infusions safely reduce risk of death and quicken time to recovery for the most severe COVID-19 patients. Dr. Ricordi's peer-reviewed paper has just been published in STEM CELLS Translational Medicine (SCTM) January 2021.

The clinical trial, authorized by the FDA last April, was initiated by The Cure Alliance, a 501(c)(3) non-profit organization of research scientists founded ten years ago by Dr. Ricordi for scientists around the world to share knowledge and accelerate cures of all diseases. At the start of the pandemic, all focus pivoted to ending suffering caused by COVID-19. Dr. Ricordi created a "mini-Manhattan project," the result of which has yielded this important new weapon in the arsenal against COVID-19, especially during this critical time when distribution of the new vaccines is slower than anticipated and the infection rate and death toll are still surging.

The SCTM paper describes findings from 24 patients hospitalized at University of Miami Tower or Jackson Memorial Hospital with COVID-19 who developed severe acute respiratory distress syndrome (SARS), a dangerous and often fatal complication marked by severe inflammation and fluid buildup in the lungs. Each patient received two infusions of either mesenchymal stem cells or a placebo, given days apart.

"It was a double-blind study. Neither doctors nor patients knew who received the treatment, who got the placebo," said Dr. Ricordi, the lead investigator.

At one month,100% of patients (

Dr. Ricordi's team also reports recovery time was faster among those in the treatment arm. More than half of patients treated with the UC-MSC infusions recovered and went home from the hospital within two weeks. More than 80% of the treatment group recovered by day 30, versus less than 37% in the control group.

"It's like smart bomb technology in the lungs to restore normal immune response and reverse life-threatening complications," Dr. Ricordi said.

Just one umbilical cord, donated from a caesarean section, can yield up to 10,000 doses of the COVID-19 treatment.

"Our results confirm the powerful anti-inflammatory, immunomodulatory effect of UC-MSCs. These cells have clearly inhibited the 'cytokine storm', a hallmark of severe COVID-19," said Giacomo Lanzoni, Ph.D, lead author of the SCTM paper.

"The results are critically important not only for COVID-19 but also for other diseases characterized by aberrant and hyper-inflammatory immune responses, such as autoimmune Type 1 Diabetes. We are very much looking forward to applying these cells in clinical trials to halt the progression of Type 1 Diabetes," he added. Dr. Lanzoni is Research Assistant Professor, Diabetes Research Institute, Department of Biochemistry and Molecular Biology at the University of Miami Miller School of Medicine.

Dr. Ricordi's core team included scientists with expertise in stem cells, pulmonary disease and critical care, but it was the diabetes researchers who began to crack the code. At the DRI, Dr. Ricordi and his colleagues had been collaborating with Chinese scientists to study UC-MSCs for the treatment of diabetes Type 1. With the outbreak of the pandemic, he learned those collaborators were now testing the treatment in severely ill COVID-19 patients and reporting success. The researchers in China were soon joined by Israeli researchers, reporting as many as 100% of treated patients surviving and recovering faster than those without stem cell treatment. But none of the studies was a randomized trial, the gold standard in science.

The potential for the treatment was certainly promising. Mesenchymal cells are known to help correct immune and inflammatory responses that go awry. They also have antimicrobial activity and have been shown to promote tissue regeneration.

What's more, when given intravenously mesenchymal stem cells migrate naturally to the lungs. exactly where therapy is needed in COVID-19 patients with life-threatening acute respiratory distress syndrome,

Dr. Ricordi enlisted Dr. Lanzoni and several key collaborators at the Miller School, the University of Miami Health System, Jackson Health System, plus others internationally and across the U.S., including Arnold I. Caplan, Ph.D., of Case Western Reserve University, the first scientist to identify mesenchymal stem cells.

Funding by The Cure Alliance was greatly enhanced by a $3 million grant from North America's Building Trades Unions (NABTU). "North America's Building Trades Unions has been a major supporter of the Diabetes Research Institute since 1984, when they started a campaign to fund, and build, our state-of-the-art research and treatment facility. NABTU has continued to support our work through the years, including our mesenchymal stem cell research that helped lead the way to this clinical trial," Dr. Ricordi said.

Credit: 
The Cure Alliance

Mid-term clinical trial results show similar outcomes in promising cell therapies for CLI

image: The two therapies demonstrated similar mid-term safety and efficacy, while each cell therapy had its unique advantages and are recommended for certain conditions: for example, PBMNCs for patients with 2 or more critical ischemic limbs and PCCs for patients with significant pain.

Image: 
AlphaMed Press

Durham, NC - Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise in treating angiitis-induced critical limb ischemia were released today in STEM CELLS Translational Medicine. The study, by researchers at Zhongshan Hospital/Fudan University in Shanghai, compared how transplantation of peripheral blood mononuclear cells fared versus transplantation of purified CD34+ cells in treating this condition.

It revealed both therapies yielded satisfactory results and provided evidence for more precise application of cell therapy under different conditions, the researchers say.

Critical limb ischemia (CLI) is a type of peripheral artery disease caused by severe blockage in the arteries of the lower extremities, which markedly reduces blood-flow. Angiitis-induced CLI (AICLI) occurs when the CLI is the result of inflammation of the walls of small blood vessels. This chronic condition results in severe pain in the feet or toes, even while resting. Left untreated, the complications of CLI often result in amputation.

"Cell transplantation, such as purified CD34+ cells (PCCs), which are multipotent hematopoietic stem cells, and peripheral blood mononuclear cells (PBMNCs), which are a mixture of highly specialized immune cells including T cells, NK cells and more, is gradually being used as a promising treatment for AICLI," explained Zhihui Dong, M.D, who along with Weiguo Fu, M.D, led the investigation. "The aim of our trial was to compare the mid-term safety and efficacy between the two groups and determine their respective advantages."

From April 2014 to September 2019, 50 AICLI patients were equally allocated to the two treatment groups. At the 36-month follow-up, 47 patients remained. The endpoints assessed were major amputation-free survival and total amputation-free survival. At six months after treatment these had been 96 percent and 84 percent in the PBMNCs group, and 96 percent and 72 percent in the PCCs group, respectively - rates that remained stable at the 12- and 24-month periods, too. The mid-term trial period focused on in this report - 36 months - once again confirmed stability.

"The PCCs group had a significant higher probability of earlier rest pain relief than the PBMNCs group, while earlier significant improvements in the Rutherford classification (which describes seven stages of peripheral artery disease) were observed in the PBMNCs group. Accordingly, PCCs would be preferred for patients with significant pain, while PBMNCs may be a good option for patients with two or more critically ischemic limbs," Dr. Fu noted.

Additionally the study compared the therapies' cost effectiveness and found that PCCs treatment was less cost-effective compared to PBMNCs treatment, mainly due to the extra cost of the purification process. "This finding is interesting and useful for future clinical trials in which we could consider avoiding purifying PBMNC into PCCs, thus reducing the cost of trials," Dr. Dong said. "The next step should be to verify our outcomes in long-term trials involving larger numbers of patients."

"The outcomes provided in this study of two cell therapies for the treatment AICLI show both to be effective and safe," said Anthony Atala, MD, Editor-in-Chief of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine. "This finding is promising and useful for the planning of future clinical trials."

Credit: 
AlphaMed Press